参考文献/References:
[1]Jiang G,Luk AO,Tam CHT,et al.Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 Diabetes[J].Diabetes,2022,71(3):520-529.[2]Lei Q,Xu F,Liang S,et al.Clinical Acute Kidney Injury and Histologic Acute Tubular-Interstitial Injury and Their Prognosis in Diabetic Nephropathy [J].Nephron,2022,146(4):351-359.[3]Bu L,Dai O,Zhou F,et al.Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesis[J].Biomed Pharmacother,2020,132:110855.[4]樊思轩,舒丽莎,任美颖.基于PI3K/Akt信号通路探讨甲基莲心碱对HeLa细胞的影响[J].中成药,2023,45(7):2185-2192.[5]庄葛,吴霞,石帅.温胆汤加减联合高通量血透对糖尿病肾病的抗氧化及抗微炎症作用观察[J].中国中西医结合肾病杂志,2019,20(2):163-165. [6]Samsu N.Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment[J].Biomed Res Int,2021,2021:1497449.[7]Jin Q,Liu T,Qiao Y,et al.Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols[J].Front Immunol,2023,14:1185317.[8]Qi C,Mao X,Zhang Z,et al.Classification and Differential Diagnosis of Diabetic Nephropathy[J].J Diabetes Res,2017,2017:8637138.[9]Ceccarelli Ceccarelli D,Paleari R,Solerte B,et al.Re-thinking diabetic nephropathy: Microalbuminuria is just a piece of the diagnostic puzzle[J].Clin Chim Acta,2022,524:146-153.[10]Thakur SK,Dhakal SP,Parajuli S,et al.Microalbuminuria and Its Risk Factors in Type 2 Diabetic Patients[J].J Nepal Health Res Counc,2019,17(1):61-65.[11]Xiong Y,Zhu W,Xu Q,et al.Sleeve Gastrectomy Attenuates Diabetic Nephropathy by Upregulating Nephrin Expressions in Diabetic Obese Rats[J].Obesity Surgery,2020,30(8):2893-2904.[12]Sagoo MK,Gnudi L.Diabetic Nephropathy: An Overview[J].Methods in Molecular Biology (Clifton,NJ),2020,2067:3-7.[13]Fu Y,Sun Y,Wang M,et al.Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism [J].Cell Metabolism,2020,32(6):1052-1062.e8.[14]王瑞瑞,姜国清.血清GSH-PX、MDA及eNOS对2型糖尿病患者胰岛素抵抗的诊断意义[J].吉林医学,2023,44(11):3095-3097.[15]郑伟,海军,宋晓雪,等.甲基莲心碱对肝缺血再灌注损伤模型小鼠氧化应激和炎症反应的影响[J].中国药房,2018,29(15):2068-2072. [16]Calle P,Hotter G.Macrophage Phenotype and Fibrosis in Diabetic Nephropathy[J].Int J Mol Sci,2020,21(8):2806.[17]Chang WW,Liang W,Yao XM,et al.Tumour necrosis factor-related apoptosis-inducing ligand expression in patients with diabetic nephropathy[J].J Renin Angiotensin Aldosterone Syst,2018,19(3):1470320318785744.[18]Campolo M,Paterniti I,Siracusa R,et al.TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson’s diseases in vivo model[J].Brain Behav Immun,2019,76:236-247.[19]Hou L,Sun F,Sun W,et al.Lesion of the Locus Coeruleus Damages Learning and Memory Performance in Paraquat and Maneb-induced Mouse Parkinson’s Disease Model[J].Neuroscience,2019,419:129-140.[20]Somensi N,Lopes SC,Gasparotto J,et al.Role of toll-like receptor 4 and sex in 6-hydroxydopamine-induced behavioral impairments and neurodegeneration in mice[J].Neurochem Int,2021,151:105215.
相似文献/References:
[1]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Journal of Medical Information,2018,31(07):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[2]何丽杰.中西医治疗糖尿病肾病的临床效果分析[J].医学信息,2018,31(10):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
HE Li-jie.Clinical Effect Analysis of Diabetic Nephropathy Treated by Chinese and Western Medicine[J].Journal of Medical Information,2018,31(07):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
[3]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,31(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(07):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[4]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,31(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Journal of Medical Information,2018,31(07):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[5]陆新虹,温玉洁,胡 欣,等.α-硫辛酸对2型糖尿病肾病患者
血清内脂素的影响研究[J].医学信息,2018,31(14):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
LU Xin-hong,WEN Yu-jie,HU Xin,et al.Effect of α-lipoic Acid on Serum Visfatin in Patients with
Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(07):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
[6]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,31(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Journal of Medical Information,2018,31(07):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
[7]李志俊,王 利,王 浩.姜黄素改善糖尿病肾病的作用机制研究[J].医学信息,2018,31(24):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
LI Zhi-jun,WANG Li,WANG Hao.Study on the Mechanism of Curcumin in Improving Diabetic Nephropathy[J].Journal of Medical Information,2018,31(07):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
[8]肖学秀.益气活血汤联合西药治疗早期糖尿病肾病的临床观察[J].医学信息,2019,32(02):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
XIAO Xue-xiu.Clinical Observation of Yiqi Huoxue Decoction Combined with Western Medicine in Treating Earlyn Diabetic Nephropathy[J].Journal of Medical Information,2019,32(07):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
[9]张国艳,张佳田,隋洪玉.糖尿病肾病大鼠动物模型建立及INF-α干预机制研究[J].医学信息,2019,32(05):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
ZHANG Guo-yan,ZHANG Jia-tian,SUI Hong-yu.Establishment of Animal Model of Diabetic Nephropathy Rats and Study of INF-α Intervention Mechanism[J].Journal of Medical Information,2019,32(07):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
[10]吴怡琪,卢 文.皮肤AGEs荧光检测对糖尿病肾病的临床意义[J].医学信息,2019,32(06):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]
WU Yi-qi,LU Wen.Clinical Significance of Skin AGEs Fluorescence Detection in Diabetic Kidney Disease[J].Journal of Medical Information,2019,32(07):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]